NEW TREATMENT FOCUSED ON EWING'S SARCOMA
Dear all..another interesting trial conducted on Ewing's sarcoma - a cancer that affects in or near the bones mainly in teenage boys. The drug under case study is figitumumab which was found to be more effective in treating this sarcoma. The drug must undergo two more phases of testing, however, according to a report published in the Dec. 23 online edition of "The Lancet Oncology".
Patients did experience some side effects, such as deep venous thrombosis, back pain and vomiting in the first phase of clinical trials while some of the patients appeared to respond well to the drug, the study authors noted.
"Figitumumab is well-tolerated and has antitumor activity in Ewing's sarcoma, warranting further investigation in this disease," the researchers wrote. "Our results show that figitumumab can be safe for both adult and pediatric sarcoma patients, and has single-agent antitumor activity in different sarcoma subtypes, including Ewing's sarcoma."
source : latest pharma news @www.drugs.com